Seeing Is Believing
Talaris Therapeutics's activity chart (see below) currently has 16 price targets and 12 ratings on display.
Analysts average stock forecasts to be materialized ratio is 43.33% with an average time for these price targets to be met of 135.83 days.
Most recent stock forecast was given by MANI FOROOHAR from LEERINK on 21-May-2023. First documented stock forecast 01-Jun-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 20-Oct-2022
$20
$-5.69 (-22.15%)
$7
3 years 5 months 4 days ago
(21-May-2023)
1/6 (16.67%)
$-6.92 (-25.71%)
160
Buy Since 20-Oct-2022
$12
3 years 6 months 8 days ago
(17-Apr-2023)
2/3 (66.67%)
$-1.69 (-12.34%)
86
Hold Since 09-Sep-2022
$6
$-19.69 (-76.64%)
$6
3 years 8 months 2 days ago
(23-Feb-2023)
4/6 (66.67%)
$-12.23 (-67.09%)
217
What is TALS (Talaris Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on TALS (Talaris Therapeutics)?
Which analyst has the most public recommendations on TALS (Talaris Therapeutics)?
Which analyst is the currently most bullish on TALS (Talaris Therapeutics)?
Which analyst is the currently most reserved on TALS (Talaris Therapeutics)?